Menu

绥美凯的价格

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Inbec is a three-in-one compound drug for the treatment of human immunodeficiency virus (HIV) infection. It can not only be used for adult patients, but also has good therapeutic effects on adolescents over 12 years old (weighing more than 40kg). Suimeikai Inbec has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line treatment of choice for patients with newly diagnosed HIV infection, and has good viral suppression effects. In addition, Suimeikai (Domitabalamid Tablets) only needs to be taken once a day, which reduces the patient's medication burden and improves the patient's quality of life.

In the SINGLE trial, in the 48-week primary analysis, the proportion of patients achieving virological suppression was better in the dolutegravir XxXABC/3TC group than in the FTC/TDF/ETC group, p=0.003, and the same treatment difference was observed among subjects defined by baseline HIV RNA levels ((or) 100,000 copies/ml). The effect of Suimeikai Inbec in inhibiting viruses is even more obvious.

During the treatment of Trimax Inbec, the correct usage and dosage should be followed. Trimax is a fixed-dose tablet and cannot be used for patients who need dose adjustment. If the patient has special circumstances, he or she needs to change the use of other drugs according to the actual situation by an experienced doctor.

The original drug of Suimeike Inbec is relatively expensive, which is a big burden for patients who need to take the drug for a long time for treatment. Therefore, many patients choose the Indian version of Suimeike. Due to patent protection restrictions, many drugs are prohibited from being copied in most countries around the world. However, due to the protection of India's special patent laws, Indian Emcure Pharmaceuticals can produce drugs that are almost as effective as the original drugs and have high cost performance.

Price from Emcure Pharmaceutical Company in India: The specification of Suimeike produced by Emcure Pharmaceutical Company in India is 30 tablets per box, and the price is around $900. Due to the floating exchange rate, the price is not fixed. If patients want to know the specific price information of Suimeike, they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/87183.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。